who discovered glp-1 Discovery of GLP-1–Based Drugs for the Treatment of Obesity Metabolic Messengers: glucagon-like peptide 1

New England Journal of Medicine 391, 15731583 (2024)

Interest in GLP-1 or GLP-1/GIP medications was also higher among individuals reporting difficulties with their finances, and who were not in work due to long-term illness or disability

It could take years of study and observation to fully understand the drugs long-term effects, both positive and negative

Good service and customer relation helpdesk

Antioxidants help protect your body from damage

Example (BPC-157 protocol): Need 6 vials for 8-week protocol Reconstitute vial 1, use for 10 days Reconstitute vial 2, use for 10 days Continue until protocol complete Powder stays stable for years, no rush to reconstitute